Early stage gastric diffuse large B-cell lymphomas: results of a randomised trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy

References

• Mihaljevic B, Nedeljkov-Jancic R, Vujicić V, Antić D, Janković S, Colović N. Primary extranodal lymphomas of gastrointestinal localizations: a single institution 5-yr experience. Med Oncol 2006; 23: 225–235
   PubMed Web of Science ®Google Scholar
• Bertulli R, Balzarotti M, Tondini C. Linfoma Non-Hodgkin del sistema gastrointestinale: storia naturale e risultati terapeutici. Argomenti di oncologia 1994; 15: 181–193
   Google Scholar
• Koch P, del Valle F, Berdel W E, Willich N A, Reers B, Hiddemann W, et al. Primary gastrointestinal non-Hodgkin's lymphoma: I. anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001; 19: 3861–3873
   PubMed Web of Science ®Google Scholar
• Brooks J J, Enterline H T. Primary gastric lymphomas. A clinic pathologic study of 58 cases with long term follow-up and literature review. Cancer 1983; 51: 701–711
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Audisio R A, Giardini R, Gennari L. Role of surgery in patients with primary non-Hodgkin's lymphoma of the stomach: an old problem revisited. Br J Surg 1993; 80: 1101–1106
   PubMed Web of Science ®Google Scholar
• Shchepotin I B, Evans S R, Shabahang M, Chorny V, Buras R R, Korobko V, et al. Primary non-Hodgkin's lymphoma of the stomach: three radical modalities of treatment in 75 patients. Ann Surg Oncol 1996; 3: 277–284
   PubMed Web of Science ®Google Scholar
• Maor M H, Velasquez W S, Muller L M, Silvermints K B. Stomach conservation in stage IE and IIE gastric non-Hodgkin's lymphoma. J Clin Oncol 1990; 8: 266–271
   PubMed Web of Science ®Google Scholar
• Fischback W, Kestel W, Kirchner T, Mössner J, Wilms K. Malignant lymphoma of the upper gastrointestinal tract. Results of a prospective study in 103 patients. Cancer 1992; 70: 1075–1080
   PubMed Web of Science ®Google Scholar
• Coiffier B, Salles G. Does surgery belong to medical history for gastric lymphomas? [comment]. Ann Oncol 1997; 8: 419–421
   PubMed Web of Science ®Google Scholar
• Rabbi C, Aitini E, Cavazzini G, Cantore M, Forghieri M E, Pari F, et al. Stomach preservation in low- and high-grade primary lymphomas: preliminary results. Haematologica 1996; 81: 15–19
   PubMed Web of Science ®Google Scholar
• Tondini C, Zanini M, Lombardi F, Valagussa P, Santoro A, Bertulli R, et al. Combined modality treatment with primary CHOP chemotherapy followed by localregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas. J Clin Oncol 1993; 11: 720–725
   PubMed Web of Science ®Google Scholar
• Binn M, Ruskoné-Fourmestraux A, Lepage E, Haioun C, Delmer A, Aegerter P, et al. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol 2003; 14: 1751–1757
   PubMed Web of Science ®Google Scholar
• Horning S J, Weller E, Kim K, Earle J D, O'Connell M J, Habermann T M, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group Study 1484. J Clin Oncol 2004; 15: 3032–3038
   Web of Science ®Google Scholar
• Raderer M, Wöhrer S, Bartsch R, Prager G, Drach J, Hejna M, et al. Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2005; 23: 8442–8446
   PubMed Web of Science ®Google Scholar
• López-Guillermo A, Colomo L, Jiménez M, Bosch F, Villamor N, Arenillas L, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005; 23: 2797–2804
   PubMed Web of Science ®Google Scholar
• Rohatiner A, d'Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397–400
   PubMed Web of Science ®Google Scholar
• Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the international extranodal lymphoma study group. Ann Oncol 2008; 19: 233–241
   PubMed Web of Science ®Google Scholar
• Gospodarowicz M. Radiotherapy in non-Hodgkin lymphomas. Ann Oncol 2008; 19(Suppl. 4)iv47–iv50
   PubMedGoogle Scholar
• Wöhrer S, Püspök A, Drach J, Hejna M, Chott A, Raderer M. Rituximab, cyclophophamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma. Ann Oncol 2004; 15: 1086–1090
   PubMed Web of Science ®Google Scholar
• Morschhauser F, Illidge T, Huglo D, Martinelli G, Paganelli G, Zinzani P L, et al. Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation. Blood 2007; 110: 54–58
   PubMed Web of Science ®Google Scholar